Inference of Tumor Evolution during Chemotherapy by Computational Modeling and In Situ Analysis of Genetic and Phenotypic Cellular DiversityVanessa Almendro, Kornélia Polyák, Yu-Kang Cheng et al.|Cell Reports|2014Cited by 283
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersÅslaug Helland, David D.L. Bowtell, Michael S. Anglesio et al.|PLoS ONE|2011Cited by 219
Genome-wide DNA methylation profiles in progression to in situand invasive carcinoma of the breast with impact on gene transcription and prognosisThomas Fleischer, Vessela N. Kristensen, Jörg Tost et al.|Genome biology|2014Cited by 179
TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer PatientsAnn Rita Halvorsen, Åslaug Helland|Frontiers in Genetics|2016Cited by 120
Intratumor heterogeneity defines treatment‐resistant <scp>HER</scp> 2+ breast tumorsInga Hansine Rye, Hege G. Russnes, Anna Barbro Sætersdal et al.|Molecular Oncology|2018Cited by 102